SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-031872
Filing Date
2021-12-17
Accepted
2021-12-17 16:40:17
Documents
16
Period of Report
2021-12-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40413
2 ex5-1.htm EX-5.1 23956
3 ex99-1.htm EX-99.1 18425
4 ex5-1_1.jpg GRAPHIC 8874
5 ex5-1_2.jpg GRAPHIC 8894
  Complete submission text file 0001493152-21-031872.txt   292819

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE pulm-20211217.xsd EX-101.SCH 3028
7 XBRL LABEL FILE pulm-20211217_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE pulm-20211217_pre.xml EX-101.PRE 22361
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3600
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 211502164
SIC: 2834 Pharmaceutical Preparations